DEADLINE ALERT for RXT, CAPR, BE, PRCT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com.

Rackspace Technology, Inc. (NASDAQ: RXT)
Class Period: May 7, 2026 – July 8, 2026
Lead Plaintiff Deadline: September 28, 2026

The complaint filed in this class action alleges that between May 7, 2026 and July 8, 2026, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) the Company’s enterprise AI efforts would require Rackspace to significantly re-prioritize its capacity and capital away from the profitable Private Cloud segment; (2) that Rackspace’s Public Cloud revenue was declining as customers contracted directly with hyperscale cloud platforms; (3) that, as a result, Rackspace was likely to significantly reduce a material portion of its Public Cloud infrastructure resale business; (4) as a result, the Company’s fiscal year 2026 revenue would be significantly impacted; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Capricor Therapeutics, Inc. (NASDAQ: CAPR)
Class Period: December 17, 2025 – July 26, 2026
Lead Plaintiff Deadline: September 28, 2026

Between December 17, 2025 and July 26, 2026, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel; (2) that the FDA had not agreed to those changes before the Company resubmitted the Deramiocel BLA; (3) that, as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of Deramiocel; (4) that, as a result of the foregoing, there was a substantial risk to regulatory approval of Deramiocel for the treatment of Duchenne muscular dystrophy; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Bloom Energy Corporation (NYSE: BE)
Class Period: February 27, 2025 – July 8, 2026
Lead Plaintiff Deadline: September 28, 2026

The complaint filed in this class action alleges that between February 27, 2025 and July 8, 2026, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Bloom Energy obtained scandium through intermediaries who sourced the metal from China; (2) that, as a result, the Company understated the extent to which it relied on scandium from China; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
Class Period: February 28, 2024 – February 25, 2026
Lead Plaintiff Deadline: September 22, 2026

The complaint filed in this class action alleges that between February 28, 2024 and February 25, 2026, Defendants made materially false and/or misleading statements regarding the Company’s business, operations, and financial condition. Specifically, Defendants failed to disclose to investors that: (1) Procept used an extensive discount program designed to incentivize customers to place bulk handpiece orders in excess of procedure demand; (2) the undisclosed discount program artificially and unsustainably inflated Procept’s reported U.S. handpiece unit sales and revenues by pulling forward sales at the expense of future periods; (3) the discount program caused customer handpiece orders to materially exceed underlying procedure demand throughout the Class Period, and this differential materially increased over time; (4) Procept’s surplus of U.S. handpiece sales relative to procedures created excess field inventory and overstocking among its customers, totaling more than 10,000 excess units by the end of the Class Period; (5) as a result, Defendants materially overstated Procept’s handpiece unit sales and the utilization of its field Systems; (6) Procept was exposed to undisclosed risks of significant operational and financial harm; and (7) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com